Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo

Inflamm Res. 2015 Dec;64(12):1005-21. doi: 10.1007/s00011-015-0886-x.

Abstract

Aim and objective: Two structurally related flavonoids found in Cyclopia subternata, namely vicenin-2 and scolymoside, were examined for its effects on inflammatory responses by monitoring the effects of vicenin-2 and scolymoside on lipopolysaccharide (LPS)-mediated vascular inflammatory responses.

Methods: The anti-inflammatory activities of vicenin-2 and scolymoside were determined by measuring permeability,monocytes adhesion and migration, and activation of pro-inflammatory proteins in LPS-activated HUVECs and mice.

Results: We found that post-treatment of each compound inhibited LPS-induced barrier disruption, expression of cell adhesion molecules (CAMs), and adhesion/transendothelial migration of human neutrophils to human endothelial cells. Each compound induced potent inhibition of phorbol-12-myristate 13-acetate (PMA) and LPS-induced endothelial cell protein C receptor (EPCR)shedding. It also suppressed LPS-induced hyperpermeability and leukocytes migration in vivo. Furthermore,each compound suppressed the production of tumor necrosis factor-α (TNF-α) or Interleukin (IL)-6 and the activation of nuclear factor-κB (NF-κB) or extracellular regulated kinases (ERK) 1/2 by LPS. Moreover, posttreatment with each compound resulted in reduced LPS-induced lethal endotoxemia.

Conclusion: Vicenin-2 and scolymoside possess anti-inflammatory functions by inhibiting hyperpermeability,expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / biosynthesis
  • ADAM Proteins / genetics
  • ADAM17 Protein
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Apigenin / pharmacology*
  • Cell Adhesion / drug effects
  • Cell Membrane Permeability / drug effects
  • Cell Movement / drug effects
  • Glucosides / pharmacology*
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Humans
  • Interleukin-6 / biosynthesis
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / pharmacology
  • Luteolin / pharmacology*
  • Macrophage Activation / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Monocytes / drug effects
  • Tetradecanoylphorbol Acetate / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Glucosides
  • Interleukin-6
  • Lipopolysaccharides
  • apigenin-6,8-di-C-glycopyranoside
  • interleukin-6, mouse
  • scolymoside
  • Apigenin
  • ADAM Proteins
  • ADAM17 Protein
  • Luteolin
  • Tetradecanoylphorbol Acetate